Tag: biosimilars vs generics
Biosimilars are billed differently than generics under Medicare Part B. Each has its own HCPCS code and payment rate based on its ASP plus 6% of the reference product’s price. This system encourages biosimilar entry but doesn’t strongly incentivize switching. Learn how billing works and why adoption remains low in the U.S.
Medications
Archives
Recent-posts
Alpelisib Cost Breakdown: How Much Patients Really Pay
Sep, 23 2025
Managing Medication Allergies and Finding Safe Alternatives
Dec, 10 2025
Combination Cholesterol Therapy with Reduced Statin Doses: A Smarter Approach
Jul, 27 2026
IBS vs. IBD: Understanding the Difference Between Functional and Inflammatory Bowel Disorders
May, 4 2026
Exploring Top Alternatives to Isotroin in 2024 for Effective Acne Management
Oct, 18 2024